Skip to main content
Schizophrenia Bulletin Open logoLink to Schizophrenia Bulletin Open
. 2020 Aug 31;1(1):sgaa046. doi: 10.1093/schizbullopen/sgaa046

The Prevalence of Psychotic Experiences in Autism Spectrum Disorder and Autistic Traits: A Systematic Review and Meta-analysis

Tomoki Kiyono 1,✉, Masaya Morita 1, Ryo Morishima 1, Shinya Fujikawa 1, Syudo Yamasaki 2, Atsushi Nishida 2, Shuntaro Ando 1, Kiyoto Kasai 1,3
PMCID: PMC13701002  PMID: 42936685

Abstract

Several reports have highlighted an association between psychotic experiences (PEs) and autism spectrum disorder/autistic traits; however, no systematic review of the evidence has been done. We searched PubMed, PsycINFO, Web of Science, and Cochrane database on November 20, 2018, for studies providing statistical results on the association between PEs and autism spectrum disorder/autistic traits. Meta-analyses were conducted for both the prevalence of PEs in autism spectrum disorder and the correlation coefficients between PEs and autistic traits. Subgroup analyses were conducted for each PE subtype. Among the 17 included studies, 9 had data about prevalence and 8 had data about correlation. The pooled prevalence of PEs in autism spectrum disorder was 24% (95% confidence interval [CI] 14%–34%). However, subanalyses found that prevalence varied between PE subtypes (hallucinations, 6% [95% CI 1%–11%] and delusions, 45% [95% CI 0%–99%]). Pooled results showed that PEs and autistic traits had a weak to medium correlation (r = .34 [95% CI 0.27–0.41]). Based on our meta-analysis, PEs seem to be more prevalent in individuals with autism spectrum disorder/autistic traits than in the general population, but this finding may vary according to the PE subtype. Future studies should focus on statistical results for each PE subtype separately. More studies should be conducted to clarify the relationship between autism spectrum disorder/autistic traits and PEs by subtype.

Keywords: hallucinations, delusions, correlation

Introduction

Psychotic experiences (PEs), usually defined as subthreshold hallucinations and delusions not due to psychotic disorders, are estimated to have a prevalence in the general population of 5% to 12%.1–3 Some studies also include negative symptoms, such as affective flattening and anhedonia, in the definition of PEs,4,5 along with the positive symptoms (hallucinations and delusions). PEs are considered to be on a continuum within the schizophrenia spectrum, and they may predict the future onset of schizophrenia.6,7 PEs are sometimes confused with schizotypal traits; however, usually schizotypal traits are less severe and more persistent.8 Recent research has also linked PEs with future onset of a wide range of mental health problems other than schizophrenia, such as affective disorders9,10 and anxiety disorders9,10 as well as suicide.11 Therefore, PEs are regarded as indicative of important mental health problems. Recent research has focused on factors that may predict the onset of PEs.

Autism spectrum disorder is a neurodevelopmental disorder characterized by difficulties in social communication and social interaction, repetitive behaviors, and restricted interests starting early in the developmental period,12 while autistic traits are attenuated characteristics of autism spectrum disorder found in the general population.13,14 The characteristics of autism spectrum disorder form a continuum; from severe autism to less severe autistic traits. There are several studies reporting that the presence of autism spectrum disorders or autistic traits could be a significant predictor of PEs.15–18 One study reported that individuals with autism spectrum disorder had 2.8 times higher odds of having PEs than the general population.16 However, another study found that this relationship was restricted to negative symptoms of PEs, with positive symptoms of PEs not being strongly associated with autistic traits.5 These inconsistent results indicate the necessity of systematic evidence for the relationship between PEs and autism spectrum disorder/autistic traits. However, such evidence is lacking. Therefore, we conducted a systematic review and meta-analyses to fill this gap. Given that autism spectrum disorder and autistic traits form a continuum,19 we sought statistical results on autism spectrum disorder and autistic traits with the view that both sets of results would be helpful for future investigations. Although several systematic reports and meta-analyses have shown elevated risks of schizophrenia and schizotypal traits20–24 in individuals with autism spectrum disorder/autistic traits, we considered that reporting systematic evidence about the association with PEs separately is clinically important, because PEs are not only associated with schizophrenia but also with a wide range of mental health problems.

Methods

Protocol and Registration

Before our search, we created a review protocol following the Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) 2015 statement25,26 and registered the protocol in the PROSPERO register (registration number: CRD42018112060, https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=112060). When we created our protocol and ran our search, there were no up-to-date meta-analyses about the relationship between autism spectrum disorder/autistic traits and schizophrenia and schizotypal traits, so we initially planned to include studies on these relationships. However, during our selection process, several systematic evidence for these relationships were published.22–24

Literature Search

We searched for studies providing statistical results on the association between PEs and autism spectrum disorder/autistic traits. Because the definitions and assessment methods of PEs vastly differ between studies, our search strategy followed a systematic review that encompassed a wide range of PEs,27 including hallucinations, delusions, and negative symptoms. Autism was first separated from psychotic disorders in 1980, so we searched for the studies published after January 1980.

Our literature search was conducted in PubMed, PsycINFO, Web of Science, and the Cochrane database on November 20, 2018. Our search in PubMed was as follows: (Anhedonia[MeSH] OR Psychotic Disorders[MeSH] OR Delusions[MeSH] OR Hallucinations[MeSH] OR Illusions[MeSH] OR Schizotypal Personality Disorder[MeSH] OR Paranoid Disorders[MeSH] OR Schizophrenia Spectrum and Other Psychotic Disorders[MeSH] OR Schizoid Personality Disorder[MeSH] OR psychotic-like experience* OR psychotic like experience* OR psychotic experience* OR psychosis-like experience* OR sub-clinical psychotic symptom* OR sub-clinical psychosis symptom* OR subclinical psychotic symptom* OR subclinical psychosis symptom* OR psychosi* OR delus* OR delusion like belief* OR delusional like experience* OR hallucinat* OR hallucinatory experience* OR illusi* OR magical th* OR bizarre idea* OR unusual experience* OR magical idea* OR anomalous experience* OR negative symptom* OR paranoi* OR disorganiz* OR cognitive disorganiz* OR schizophreni* OR schizotyp* OR schizoi*) AND (Child Development Disorders, Pervasive[MeSH] OR autis* OR autism spectrum disorder* OR autism spectrum trait* OR pervasive developmental disorder* OR Asperger syndrome* OR Kanner syndrome*). Searches in other databases were conducted similarly.

Study Selection

The literature search results were uploaded to the Covidence (https://www.covidence.org/home) database, an Internet-based software program that facilitates collaboration among reviewers during the study selection process. After duplicate studies were removed, the titles and abstracts of the remaining studies were independently screened by 2 different authors (T.K. and M.M.) to identify studies that met the following criteria. Inclusion criteria were the following (1) an original study that provided statistical results on the association between PEs and autism spectrum disorder/autistic traits, (2) peer-reviewed journal articles, and (3) articles reported in English. In addition, neither PEs nor autism spectrum disorder/autistic traits necessarily needed to be identified by diagnostic classifications, and there were no restrictions for age or gender. Exclusion criteria were the following: (1) articles pertained to PEs or autism spectrum disorder/autistic traits, not both; (2) articles involved associations between PEs and psychiatric conditions other than autism spectrum disorder/autistic traits only; (3) articles concerned associations between psychiatric conditions other than PEs and autism spectrum disorder/autistic traits only and did not show statistical results of PEs in autism spectrum disorder or autistic traits; (4) articles concerned only PEs/psychotic disorders due to medical conditions; articles focused only on (5) genetic studies or (6) on brain imaging studies and did not show statistical results of PEs in autism spectrum disorder or autistic traits; (7) articles reported in languages other than English; and (8) publications were systematic reviews, reviews, editorials, letters, medical case reports, conference abstracts, non-peer-reviewed literature, dissertations, or gray literature.

The full text of the potentially eligible studies was retrieved and independently assessed for eligibility by the same 2 reviewers. Any disagreement between the reviewers was resolved by a third reviewer (R.M.). We excluded studies reporting only the relationship between schizophrenia/schizotypal traits and autism spectrum disorder/autistic traits. Finally, we included unidentified studies that were advised to be included by experts.

Data Extraction and Quality Assessment

From the selected studies, we extracted the first author; date of study year; study design; and sample age, size, female/male ratio, and Intelligence Quotient (IQ) score. We also recorded whether the diagnostic or assessment measures for PEs and autism spectrum disorder/autistic traits, the prevalence of PEs in autism spectrum disorder/autistic traits, and any reported correlation coefficients between PEs and autism spectrum disorder/autistic traits. The quality of the studies was assessed by using the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies (the National Heart, Lung, and Blood Institute, National Institutes of Health). We considered studies as low quality if they did not use clearly defined outcome measures. If several studies were based on the same cohort, we included the studies that were most relevant.

Data Synthesis and Analysis

We conducted meta-analyses for both the prevalence of PEs in individuals with autism spectrum disorder/autistic traits and the correlation coefficients between PEs and autism spectrum disorder/autistic traits by using the “meta” package (version 4.9-5) in R software for Windows (version 3.6.0, The R Foundation for Statistical Computing). If more than 2 subtypes of PEs were reported in the same study, the PE subtype with the larger prevalence or correlation was chosen. In studies reporting odds ratios (ORs) only, we transformed OR to correlation coefficients by the approximation (OR3/4−1)/ (OR3/4+1).28 We used random effect models because the targets were from heterogeneous groups. The random intercept logistic regression model was used for calculation. In calculating pooled prevalence, we used the “metaprop” function, and for pooled correlation, we used the “metacor” function. In the meta-analysis for correlation coefficients, Fisher’s z-transformed correlation was used. The heterogeneities of the studies were calculated by I2 statistics. I2 value of more than 50% is usually considered as having moderate to high heterogeneity. The risk of bias was estimated by funnel plot analyses and asymmetries were assessed by Egger’s regression tests. We also conducted sensitivity analyses by restricting studies to that used clearly defined PEs by diagnostic criteria and by restricting studies to that had a sample with an average age by more than 10 years old because PEs usually occur in adolescents. Subgroup analyses were conducted by restricting studies to those that showed a relationship between autism spectrum disorder/autistic traits and each symptom of PEs (hallucinations or delusions).

Results

Study Selection

Literature search yielded 22 227 studies for screening. After duplicates were removed, the titles and abstracts of the remaining 16 713 studies were screened. Of the 685 studies assessed for eligibility by their full text, 23 studies were identified.5,15–17,29–47 One study was also included by advice from experts.48 However, 9 studies had study participants who were included in more than 1 study. Therefore, after excluding 7 studies with duplications, 17 studies were included in the final analyses (supplementary figure S1) (lists of excluded 7 studies with duplications are shown in supplementary table S1). For the duplicated study, we chose those that most matched our objective with sufficient quality including appropriate confounding variables measured. We found 14 studies on PEs and autism spectrum disorder/autistic traits that lacked statistical data, 91 studies on schizophrenia or psychotic disorders and autism spectrum disorder/autistic traits, and 33 studies on schizotypal traits and autism spectrum disorder/autistic traits; these studies were not included in the final analyses.

Study Characteristics and Quality Assessment

We identified 9 studies with data for the prevalence of PEs in autism spectrum disorder/autistic traits (supplementary table S2a) and 8 studies with data for a correlation (supplementary table S2b). There were 5 longitudinal cohort studies, and the other studies had a cross-sectional design. The quality of studies is described in supplementary table S3. One study did not use valid measures for assessing autism spectrum disorder, and 4 studies did not use valid measures for assessing PEs.

Results of Meta-analyses on the Prevalence of PEs in Autism Spectrum Disorder

The results of the meta-analysis on the prevalence of PEs in autism spectrum disorder are shown in figure 1. The prevalence of PEs in autism spectrum disorder ranged from 1.6% to 76%. The calculated overall prevalence was 24% [95% confidence interval (CI) 14%–34%]. The heterogeneity of the included studies was high (I2 = 97%). The risk of bias by funnel plot analysis is shown in supplementary figure S2a. Egger’s regression test indicated an asymmetry in the funnel plot analysis (P-value = .0030, supplementary figure S2b). After restricting studies that used clearly defined PEs by diagnostic criteria, the prevalence was 37% [95% CI 10%–65%] (supplementary figure S3a), and restricting studies with average sample age more than 10, the prevalence was 31% [95% CI 13%–49%].

Fig. 1.

Fig. 1.

Pooled prevalence of psychotic experiences (PEs) in autism spectrum disorder. Note: CI, confidence interval; IV, inverse variance.

Subgroup analyses showed that hallucinations and delusions in autism spectrum disorder were 6% [95% CI 1%–11%] and 45% [95% CI 0%–99%], respectively (figures 2a and 2b). Funnel plot analysis is shown in supplementary figures S4 and S5. We did not find studies that showed the prevalence of negative symptoms in autism spectrum disorder.

Fig. 2.

Fig. 2.

(a) Subanalysis about the pooled prevalence of hallucinations in autism spectrum disorder. (b) Subanalysis about the pooled prevalence of delusions in autism spectrum disorder. Note: CI, confidence interval; IV, inverse variance.

Results of Meta-analysis About the Correlation Between PEs and Autistic Traits

The result of the meta-analysis on the correlation between PEs and autistic traits is shown in figure 3. Correlation between PEs and autistic traits ranged from 0.13 to 0.57. The calculated overall correlation was 0.34 [95% CI 0.27–0.41]. The heterogeneity of included studies was high (I2 = 89%) but Egger’s regression test did not indicate an asymmetry in the funnel plot analysis (P-value = .25, supplementary figures S6a and S6b). All studies clearly defined PEs by diagnostic criteria. After restricting studies with an average sample age of more than 10, the correlation was 0.35 [95% CI 0.28–0.42] (supplementary figure S7). We could not conduct a subanalysis about negative symptoms due to lack of studies.

Fig. 3.

Fig. 3.

Pooled correlation between psychotic experiences (PEs) and autistic traits. Note: CI, confidence interval; IV, inverse variance.

Discussion

To the best of our knowledge, this study is the first to report systematic evidence on the relationship between PEs and autism spectrum disorder/autistic traits. Our meta-analyses showed that the prevalence of PEs in autism spectrum disorder may be as high as 24% and that PEs and autistic traits have a weak correlation (r = .34). However, subanalyses found that the prevalence may vary between PE subtypes.

In contrast to the prevalence of PEs in the general population (5% to 12%),1–3 the prevalence among individuals with autism spectrum disorder was found to be higher (24%) in our meta-analysis. Therefore, the prevalence of PEs in autism spectrum disorder could be 2 to 5 times higher than in the general population. Due to a lack of studies, we could not directly calculate pooled ORs. A recent systematic review reported that individuals with autism spectrum disorder have 3.55 times higher odds of having schizophrenia than healthy controls,22 and the high prevalence of PEs in autism spectrum disorder observed in our study is similar. Both PEs and schizophrenia seem to be more prevalent in individuals with autism spectrum disorder than in the general population. The reason for this high prevalence has not been well investigated. People with autism spectrum disorder may have increased vulnerability for developing PEs. As childhood adverse experiences such as peer victimization are common in people with autism spectrum disorder,49 such adversities may mediate their relationship. Other neuropsychiatric problems17 or anatomical factors50 may also contribute to this association. In addition, there is a possibility of false positives. Some aspects of people with autism spectrum disorder such as “noticing small sounds” and “seeing patterns” might be mislabeled as PEs. We suggest that future studies should look further for the association between these 2 conditions.

We also found that the prevalence of each PE subtype differs among individuals with autism spectrum disorder (hallucinations, 6%; delusions, 45%). This finding is in contrast to previous reports about the prevalence of each PE subtype in the general population.1,2,7 A systematic review1 showed that the median prevalence of hallucinations, delusions, and commingled hallucinations and delusions in the general population is 6%, 4.9%, and 6.7%, respectively. Based on our meta-analysis, the prevalence of hallucinations in individuals with autism spectrum disorder seems to be comparable to that in the general population. In contrast, the prevalence of delusions could be higher than hallucinations. However, the CI of the subanalysis was too wide to make a conclusion. If this difference of prevalence between PEs subtype truly exists, it may be attributable to the characteristics of autism spectrum disorder; people with autism spectrum disorder have weaknesses in social communication skills and in understanding other people’s intentions, which may result in the formation of delusional ideas about other people’s intentions. We should also consider the possibility that strong believes in people with autism spectrum disorder could be due to their difficult-to-change characteristics but could be mislabeled as delusions. Negative symptoms could be all the more difficult to be differentiated from characteristics in autism spectrum disorder and autistic traits due to their common phenotypes; however, we could not conduct a subanalysis of the prevalence of negative symptoms due to lack of studies. We suggest that future studies should show the prevalence or association of each PE subtype separately.

Although several reports have showed that autism spectrum disorder is a risk factor for schizophrenia,22,23 the different prevalence of each PE subtype in autism spectrum disorder also suggests that the nature of PEs in autism spectrum disorder may differ from symptoms in schizophrenia. The latest diagnostic criteria for schizophrenia suggest a cautious diagnosis of schizophrenia in autism spectrum disorder; a diagnosis of schizophrenia should only be made if prominent delusions or hallucinations are present in this context.12 However, as our results showed that delusions could be common in autism spectrum disorder, making an additional diagnosis of schizophrenia in autism spectrum disorder based on the existence of delusions alone may still lead to an overdiagnosis of schizophrenia. Moreover, our finding is in line with a previous report that showed psychosis in people with autism spectrum disorder has atypical features in contrast to people with psychosis only or autism spectrum disorder without psychosis.51 This study proposed a specific subtype of autism spectrum disorder linked to comorbid psychosis. Therefore, we suggest that future research should look for a better diagnostic method for people with symptoms of both psychosis and autism spectrum disorder and look further into the pathophysiology in this specific group. We also suggest that clinicians should be aware of the possibility of this specific group and should also be cautious about their diagnosis and treatment with patients with both features.

The correlation between PEs and autistic traits by our meta-analysis was 0.34, which indicates a weak to medium correlation. This correlation was similar to a recent meta-analysis that showed a correlation between positive schizotypal traits and autistic traits (r = .256).24 This previous study concluded that the correlation between schizotypal traits and autistic traits was mainly due to the negative symptoms of schizotypal traits; the positive symptoms and autistic traits showed a negative correlation. However, we could not conduct subanalysis about negative symptoms due to lack of studies, therefore could not further investigate whether a difference between positive and negative symptoms exists in the association between PEs and autistic traits.

Our study has several limitations. Firstly, the prevalence between each study varied, and the heterogeneity of studies included in the meta-analysis was high. This heterogeneity could be partly attributed to the selection of studies. The diversity in the diagnostic criteria of autism spectrum disorder/autistic traits and PEs may be related to the heterogeneity. There is also a possibility of false-positive PEs, as already mentioned. Shared characteristics of autism spectrum disorder/autistic traits and PEs may have biased our results. Moreover, although we excluded studies that clearly stated that the sample population had schizophrenia or schizotypal traits, the possibility exists that we may have included undiagnosed patients with schizophrenia or schizotypal traits. PEs are across the severity spectrum, and its divergence could have also influenced the heterogeneity between studies. Secondly, the quality of the included studies varied, and low-quality studies may have influenced the outcomes of our analyses. Some studies did not use validated tools in the diagnosis of PEs, had very small sample age, or had small sample size. Excluding such studies in the sensitivity analysis did not decrease the prevalence and correlation, although the CI was widened. Thirdly, the overall number of participants and studies included in our analyses, especially in the sub-analyses, was small, and these results, therefore, need to be interpreted with caution. Finally, although we used the search time frame for our search from 1980, as the concepts of autism spectrum disorder have further changed after 1980, it could have been better to set the time frame from 1993, when the Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) was published. However, as our final 21 included studies do not contain studies that were published before 1993, our results would not change whether we excluded studies published before 1993.

We showed systematic evidence of the relationship between PEs and autism spectrum disorder/autistic traits. Our meta-analyses found that PEs seem to be more prevalent in individuals with autism spectrum disorder/autistic traits than in the general population, but this finding may vary according to the PE subtype. The reason for this relationship is not well understood, and its causality is also uncertain. Therefore, more studies should be conducted to clarify the longitudinal relationship between PEs and autism spectrum disorder/autistic traits using validated evaluation methods.

Supplementary Material

sgaa046_suppl_Supplementary_Materials

Acknowledgment

All authors declare that they have no conflict of interest.

Funding

This work was supported by the Japanese Society for the Promotion of Science (grant numbers: JP16H06395, 16H06398, 16H06399, 16K21720, 17H05931, and 17H04244) and also supported by the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development (AMED) (grant number: JP19ek0109369), Takeda Science Foundation, UTokyo Center for Integrative Science of Human Behavior (CiSHuB), and the International Research Center for Neurointelligence (WPI-IRCN) at the University of Tokyo Institutes for Advanced Study (UTIAS).

References

  • 1. Linscott RJ, van Os J. An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol Med. 2013;43(6):1133–1149. [DOI] [PubMed] [Google Scholar]
  • 2. McGrath JJ, Saha S, Al-Hamzawi A, et al. Psychotic experiences in the general population: a cross-national analysis based on 31,261 respondents from 18 countries. JAMA Psychiatry. 2015;72(7):697–705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Maijer K, Begemann MJH, Palmen SJMC, Leucht S, Sommer IEC. Auditory hallucinations across the lifespan: a systematic review and meta-analysis. Psychol Med. 2018;48(6):879–888. [DOI] [PubMed] [Google Scholar]
  • 4. Stefanis NC, Hanssen M, Smirnis NK, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. 2002;32(2):347–358. [DOI] [PubMed] [Google Scholar]
  • 5. Taylor MJ, Robinson EB, Happé F, Bolton P, Freeman D, Ronald A. A longitudinal twin study of the association between childhood autistic traits and psychotic experiences in adolescence. Mol Autism. 2015;6:44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med. 2009;39(2):179–195. [DOI] [PubMed] [Google Scholar]
  • 7. Zammit S, Kounali D, Cannon M, et al. Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry. 2013;170(7):742–750. [DOI] [PubMed] [Google Scholar]
  • 8. Fonseca E, Debbané M. Schizotypal traits and psychotic-like experiences during adolescence: an update. Psichotema. 2017;29(1):5–17. [DOI] [PubMed] [Google Scholar]
  • 9. Healy C, Brannigan R, Dooley N, et al. Childhood and adolescent psychotic experiences and risk of mental disorder: a systematic review and meta-analysis. Psychol Med. 2019;49(10):1589–1599. [DOI] [PubMed] [Google Scholar]
  • 10. Kırlı U, Binbay T, Drukker M, et al. DSM outcomes of psychotic experiences and associated risk factors: 6-year follow-up study in a community-based sample. Psychol Med. 2019;49(8):1346–1356. [DOI] [PubMed] [Google Scholar]
  • 11. Yates K, Lång U, Cederlöf M, et al. Association of psychotic experiences with subsequent risk of suicidal ideation, suicide attempts, and suicide deaths: a systematic review and meta-analysis of longitudinal population studies. JAMA Psychiatry. 2019;76(2):180–189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013. [Google Scholar]
  • 13. Constantino JN, Todd RD. Autistic traits in the general population: a twin study. Arch Gen Psychiatry. 2003;60(5): 524–530. [DOI] [PubMed] [Google Scholar]
  • 14. Hoekstra RA, Bartels M, Cath DC, Boomsma DI. Factor structure, reliability and criterion validity of the Autism-Spectrum Quotient (AQ): a study in Dutch population and patient groups. J Autism Dev Disord. 2008;38(8):1555–1566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Bevan Jones R, Thapar A, Lewis G, Zammit S. The association between early autistic traits and psychotic experiences in adolescence. Schizophr Res. 2012;135(1-3):164–169. [DOI] [PubMed] [Google Scholar]
  • 16. Sullivan S, Rai D, Golding J, Zammit S, Steer C. The association between autism spectrum disorder and psychotic experiences in the Avon longitudinal study of parents and children (ALSPAC) birth cohort. J Am Acad Child Adolesc Psychiatry. 2013;52(8):806–814.e2. [DOI] [PubMed] [Google Scholar]
  • 17. Cederlöf M, Pettersson E, Sariaslan A, et al. The association between childhood autistic traits and adolescent psychotic experiences is explained by general neuropsychiatric problems. Am J Med Genet B Neuropsychiatr Genet. 2016;171B(2):153–159. [DOI] [PubMed] [Google Scholar]
  • 18. Hennig T, Jaya ES, Koglin U, Lincoln TM. Associations of attention-deficit/hyperactivity and other childhood disorders with psychotic experiences and disorders in adolescence. Eur Child Adolesc Psychiatry. 2017;26(4):421–431. [DOI] [PubMed] [Google Scholar]
  • 19. Abu-Akel A, Allison C, Baron-Cohen S, Heinke D. The distribution of autistic traits across the autism spectrum: evidence for discontinuous dimensional subpopulations underlying the autism continuum. Mol Autism. 2019;10:24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Chisholm K, Lin A, Abu-Akel A, Wood SJ. The association between autism and schizophrenia spectrum disorders: a review of eight alternate models of co-occurrence. Neurosci Biobehav Rev. 2015;55:173–183. [DOI] [PubMed] [Google Scholar]
  • 21. Lugo-Marín J, Magán-Maganto M, Rivero-Santana A, et al. Prevalence of psychiatric disorders in adults with autism spectrum disorder: a systematic review and meta-analysis. Res Autism Spectr Disord. 2019;59(2018):22–33. [Google Scholar]
  • 22. Zheng Z, Zheng P, Zou X. Association between schizophrenia and autism spectrum disorder: a systematic review and meta-analysis. Autism Res. 2018;11(8):1110–1119. [DOI] [PubMed] [Google Scholar]
  • 23. De Crescenzo F, Postorino V, Siracusano M, et al. Autistic symptoms in schizophrenia spectrum disorders: a systematic review and meta-analysis. Front Psychiatry. 2019;10:78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Zhou HY, Yang HX, Gong JB, et al. Revisiting the overlap between autistic and schizotypal traits in the non-clinical population using meta-analysis and network analysis. Schizophr Res. 2019;212:6–14. [DOI] [PubMed] [Google Scholar]
  • 25. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349(January):1–25. [DOI] [PubMed] [Google Scholar]
  • 26. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Rev Esp Nutr Humana y Diet. 2016;20(2):148–160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Lee KW, Chan KW, Chang WC, Lee EH, Hui CL, Chen EY. A systematic review on definitions and assessments of psychotic-like experiences. Early Interv Psychiatry. 2016;10(1):3–16. [DOI] [PubMed] [Google Scholar]
  • 28. Bonett DG. Transforming odds ratios into correlations for meta-analytic research. Am Psychol. 2007;62(3):254–255. [DOI] [PubMed] [Google Scholar]
  • 29. Kobayashi R, Murata T. Behavioral characteristics of 187 young adults with autism. Psychiatry Clin Neurosci. 1998;52(4):383–390. [DOI] [PubMed] [Google Scholar]
  • 30. Abell F, Hare DJ. An experimental investigation of the phenomenology of delusional beliefs in people with Asperger syndrome. Autism. 2005;9(5):515–531. [DOI] [PubMed] [Google Scholar]
  • 31. de Bruin EI, de Nijs PF, Verheij F, Hartman CA, Ferdinand RF. Multiple complex developmental disorder delineated from PDD-NOS. J Autism Dev Disord. 2007;37(6):1181–1191. [DOI] [PubMed] [Google Scholar]
  • 32. Mukaddes NM, Fateh R. High rates of psychiatric co-morbidity in individuals with Asperger’s disorder. World J Biol Psychiatry. 2010;11(2 Pt 2):486–492. [DOI] [PubMed] [Google Scholar]
  • 33. Lugnegård T, Hallerbäck MU, Gillberg C. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome. Res Dev Disabil. 2011;32(5):1910–1917. [DOI] [PubMed] [Google Scholar]
  • 34. Takara K, Kondo T. Autism spectrum disorder among first-visit depressed adult patients: diagnostic clues from backgrounds and past history. Gen Hosp Psychiatry. 2014;36(6):737–742. [DOI] [PubMed] [Google Scholar]
  • 35. Kyriakopoulos M, Stringaris A, Manolesou S, et al. Determination of psychosis-related clinical profiles in children with autism spectrum disorders using latent class analysis. Eur Child Adolesc Psychiatry. 2015;24(3):301–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Eussen ML, de Bruin EI, Van Gool AR, et al. Formal thought disorder in autism spectrum disorder predicts future symptom severity, but not psychosis prodrome. Eur Child Adolesc Psychiatry. 2015;24(2):163–172. [DOI] [PubMed] [Google Scholar]
  • 37. Goto A, Miyawaki D, Kusaka H, et al. High prevalence of non-psychotic delusions in children with high-functioning pervasive developmental disorder. Osaka City Med J. 2015;61(2):73–80. [PubMed] [Google Scholar]
  • 38. Gadow KD. Association of schizophrenia spectrum and autism spectrum disorder (ASD) symptoms in children with ASD and clinic controls. Res Dev Disabil. 2013;34(4):1289–1299. [DOI] [PubMed] [Google Scholar]
  • 39. Jalbrzikowski M, Krasileva KE, Marvin S, et al. Reciprocal social behavior in youths with psychotic illness and those at clinical high risk. Dev Psychopathol. 2013;25(4 Pt 1):1187–1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Abu-Akel A, Apperly IA, Wood SJ, Hansen PC, Mevorach C. Autism tendencies and psychosis proneness interactively modulate saliency cost. Schizophr Bull. 2017;43(1):142–151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Louzolo A, Gustavsson P, Tigerström L, Ingvar M, Olsson A, Petrovic P. Delusion-proneness displays comorbidity with traits of autistic-spectrum disorders and ADHD. PLoS One. 2017;12(5):e0177820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Milne E, Dickinson A, Smith R. Adults with autism spectrum conditions experience increased levels of anomalous perception. PLoS One. 2017;12(5):e0177804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Abu-Akel AM, Apperly IA, Wood SJ, Hansen PC. Autism and psychosis expressions diametrically modulate the right temporoparietal junction. Soc Neurosci. 2017;12(5):506–518. [DOI] [PubMed] [Google Scholar]
  • 44. Abu-Akel AM, Wood SJ, Hansen PC, Apperly IA. Perspective-taking abilities in the balance between autism tendencies and psychosis proneness. Proc Biol Sci. 2015;282(1808):20150563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Guyatt AL, Stergiakouli E, Martin J, et al. Association of copy number variation across the genome with neuropsychiatric traits in the general population. Am J Med Genet B Neuropsychiatr Genet. 2018;177(5):489–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Khandaker GM, Stochl J, Zammit S, Lewis G, Jones PB. A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence. Psychol Med. 2014;44(15):3229–3238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Kounali D, Zammit S, Wiles N, et al. Common versus psychopathology-specific risk factors for psychotic experiences and depression during adolescence. Psychol Med. 2014;44(12):2557–2566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Siebald C, Khandaker GM, Zammit S, Lewis G, Jones PB. Association between childhood psychiatric disorders and psychotic experiences in adolescence: a population-based longitudinal study. Compr Psychiatry. 2016;69:45–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Hoover DW, Kaufman J. Adverse childhood experiences in children with autism spectrum disorder. Curr Opin Psychiatry. 2018;31(2):128–132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Toal F, Bloemen OJ, Deeley Q, et al. Psychosis and autism: magnetic resonance imaging study of brain anatomy. Br J Psychiatry. 2009;194(5):418–425. [DOI] [PubMed] [Google Scholar]
  • 51. Larson FV, Wagner AP, Jones PB, et al. Psychosis in autism: comparison of the features of both conditions in a dually affected cohort. Br J Psychiatry. 2017;210(4):269–275. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

sgaa046_suppl_Supplementary_Materials

Articles from Schizophrenia Bulletin Open are provided here courtesy of Oxford University Press on behalf of the University of Maryland's School of Medicine, Maryland Psychiatric Research Center

RESOURCES